Specialty Pharmacy

Chiasma told it had not provided enough evidence of the drug’s efficacy to warrant an approval.

A pair of FDA final guidance documents may help drug manufacturers reduce the risk of deadly medication errors.

Blue-green algae discovered in Panama carries potent anti-cancer activity.

Current CDC testing guidelines fall short of solving the problem of undiagnosed patients with hepatitis C.

United States Preventive Services Task Force states screening for chronic obstructive pulmonary disease not be performed without symptoms of the disease.

Recent advances and updates in oncology and cancer drug development.

Gastrointestinal stromal tumors result in higher mortality than originally estimated.

TZD-based medicines effectively improve glucose uptake.

Medi-551 antibody targets the protein CD19 found on the surface of multiple myeloma stem cells.

Ocrelizumab shows potential treating both relapsing and primary progressive forms of multiple sclerosis.

Top articles of the week on Specialty Pharmacy Times.

Video game-based cognitive rehabilitation programs show promise in treating multiple sclerosis symptoms.

The impact of zidovudine, nelfinavir, and lamivudine prophylaxis in treating neonatal HIV transmission.

Antepartum, intrapartum, and postpartum antiretroviral prophylaxis can drastically reduce the chance of HIV transmission.

Pharmakon Pharmaceuticals Inc voluntarily recalls sterile compounded products due to sterility and quality concerns.

Chronic pain and hormone replacement among the most frequently used compounded medications.

Researchers explore vaccine to produce simultaneous immune response against hepatitis C and HIV.

Engineered immunogens incite the immune system to produce antibodies that show promise for an HIV vaccine.

Advanced T cell receptor sequencing may predict efficacy of immunotherapy in brain cancer treatment.

Zinbryta found to reduce cells that contribute to neurological injury caused by multiple sclerosis.

Treating hepatitis C could potentially be less expensive with generic treatments.

Top news of the day from across the health care landscape.

Duration of psoriasis at baseline impacts the odds of developing erosion in psoriatic arthritis.

Study finds fewer exchange health plans are placing specialty drugs on the highest tier.

Top news from across the health care landscape.

Tenofovir alafenamide found safer than tenofovir disoproxil fumarate in multiple trials.

Overall positive results shown in studies with Harvoni and sofosbuvir/velpatasvir.

Pfizer announced Ibrance met its primary endpoint in postmenopausal women with human epidermal growth factor receptor 2-negative (ER+, HER2-) advanced or metastatic breast cancer.